4 days ago · the approval is considered a major breakthrough in treating acute pain without opioid medications like vicodin and oxycontin. Reliance on opioids can lead to addiction. 5 days ago · nevertheless, journavx appears to be a real breakthrough drug, opening the door for a new class of pain relievers for patients to access. This is good news. This is good news.
4 days ago · the drug’s approval does not extend to chronic pain treatment. Cohen sees the breakthrough as a positive step for the future of pain management.
Kattpaccino: The Implications Are Staggering
Alinity's Biggest Regret: The Shocking Leak!